
PP62. MYELODYSPLASTIC SYNDROME WITH NUMERICAL AND STRUCTURAL CHROMOSOME ABNORMALITIES - CASE REPORT A. ARGHIR1, S. Chirieac1, N. Berbec1,2, G. Vulcan3, A. Lungeanu1
1. Victor Babes National Institute, Bucharest, Romania 2. Carol Davila University of Medicine and Pharmacy, Bucharest, Romania 3. Emergency Clinical Hospital, Brasov, Romania
e-mail: albinuta@vbabes.ro
*Corresponding Author: page: 75
|
Abstract
Myelodysplastic syndromes (MDSs) are a group of clonal hematological malignancies, characterized by hyperproliferative but ineffective hematopoiesis. Cytogenetic abnormalities are identified in 30 to 70% of de novo MDS. We present the case of a 54 year-old male patient with multiple chromosomal aberrations revealed during MDS evolution. Cytogenetic investigation has been performed by classical chromosome studies (GTG banding) and standard FISH techniques. Complex numerical and structural anomalies were identified in bone marrow cells. Modal chromosome number was 51 (48-51). Hyperdiploidy resulted from trisomy 1, 8, 14, 21 and the presence of supernumerary marker similar to C group. Structural rearrangements of autosomes 1 and 19 were observed. FISH with chromosome 14 painting and centromeric probe for chromosome 8 confirmed the classical cytogenetic findings. Quantitative alterations of chromosome 8 (either total or partial trisomy 8) are commonly found in MDS, as well as trisomy 14. Also, trisomy 21 is the second most frequent acquired trisomy in adult MDS. In our case, frequently described trisomies associate to structural aberrations that necessitate further studies for a detailed characterization. The impact of these complex genomic alterations on disease evolution has been unfavorable. The patient progressed towards acute myeloid leukemia and died of infectious complication. Acknowledgements: National Program for Research of Excelence CEEX MIII, Project no. 15/2006.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|